Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
2(15%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
2
15%
Ph phase_3
1
8%
Ph early_phase_1
1
8%
Ph not_applicable
9
69%

Phase Distribution

3

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution13 total trials
Early Phase 1First-in-human
1(7.7%)
Phase 1Safety & dosage
2(15.4%)
Phase 3Large-scale testing
1(7.7%)
N/ANon-phased studies
9(69.2%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

90.9%

10 of 11 finished

Non-Completion Rate

9.1%

1 ended early

Currently Active

2

trials recruiting

Total Trials

13

all time

Status Distribution
Active(2)
Completed(10)
Terminated(1)

Detailed Status

Completed10
Recruiting2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (7.7%)
Phase 12 (15.4%)
Phase 31 (7.7%)
N/A9 (69.2%)

Trials by Status

recruiting215%
withdrawn18%
completed1077%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
DRUG
Total Trials
13